Artificial Pancreas

ORLANDO — An inhaled insulin was noninferior to usual care for change in HbA1c and continuous glucose monitoring metrics among adults with type 1 diabetes, according to data from the INHALE-3 trial.

BOSTON — Continuous glucose monitoring has transformed the field of diabetes over the past 25 years. The technology can be used by both providers and people with diabetes to improve disease management, according to a speaker at ENDO 2024.

A miniature-sized automated insulin delivery system cleared by the FDA in 2023 is now compatible with a new-generation continuous glucose monitor, according to a press release.

The FDA has authorized CamAPS FX, a closed loop algorithm that links compatible continuous glucose monitors and insulin pumps into an artificial pancreas system for patients with type 1 diabetes aged 2 years and older.

The FDA authorized a closed-loop algorithm for an artificial pancreas system for use by people with type 1 diabetes aged 2 years and older, including during pregnancy, according to press release from Cambridge University.

Hybrid closed-loop insulin delivery systems are more cost-effective for treating type 1 diabetes than immune therapies unless the effects of immune therapies are persistent over a lifetime after one course, according to a speaker.

Pregnant women with type 1 diabetes achieved a higher time in range and had fewer complications with use of a hybrid closed-loop insulin delivery system compared with continuous glucose monitoring alone, according to a speaker.

The FDA granted 510(k) clearance for an automated insulin delivery system that can measure the volume and flow of insulin within every micro-dose, according to an industry press release.

An automated insulin delivery system controlled by an artificial intelligence machine learning model may perform just as well as a system using a traditional equation-based insulin dosing algorithm, according to a speaker.

The use of continuous glucose monitoring and hybrid closed-loop insulin delivery systems increased among youths with type 1 diabetes from 2016-2017 to 2020-2021 and may have helped reduce HbA1c, according to a brief report.